Compositions of G-CSF and TNF-BP for prophylaxis and treatment o

Details Compositions of G-CSF and TNF-BP for prophylaxis and treatment o Compositions of G-CSF and TNF-BP for prophylaxis and treatment o

1995-05-05

1998-05-12

Scheiner, Toni R.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 2, 514885, 514921, 424 851, 424810, 4241341, 530350, 530351, C07K 14715, C07K 1453, A61K 3816, A61K 3819

Patent

active

057505039

ABSTRACT:
The present invention is directed to products containing G-CSF and a TNF binding protein and compositions of G-CSF and TNF-BP, and methods of treating and/or preventing septic shock by administering the products and compositions of the invention.

REFERENCES:
patent: 4810643 (1989-03-01), Souza
patent: 4999291 (1991-03-01), Souza
patent: 5610279 (1997-03-01), Brockhaus et al.
Ashkenazi, et al., Proceedings of The National Academy of Sciences, vol. 88, No. 23, pp. 10535-10539 (1991).
Teng, et al., Prevention of Runting and Cachexia by a Chimeric TNF Receptor-Fc Protein, Clinical Immunology and Immunopathology, vol. 69, No. 2, pp. 215-222, (1993).
Steiner, Bio/technology 12:1313 (1994).
Spriggo et al in Tumor Necros Factors . . . , Raven Press, 1185 Ave. of Americas, NY., NY., 10036, 1992, p. 383.
Zwierzina, Stem Cells 11:144-153, (1993).
Quesenberry, Experimental Hematology 23: 185-186 (1995).
Natanson C. et al (1994) annals of Internal Medicine 120(9):771-783.
Rhein, R. (1993) Biotechnology, Newswatch Oct. 3 pp. 2,3.
Stephenson J. (1996) JAMA 275(11):823-824.
Evans T.J. et al (1994) J. Exp. Med. 180(6):2173-2179.
Aderke, D. Cytokine & Growth Factor Reviews 7(3):231-240, 1996.
Loetscher, et al., Internatioanl Congress Series Excepta Medical 2:455-662 (1993) "Efficacy of a chimeric TNFR-IgG fusion protein . . . ".
Calandra, et al., Progress in Clinical and Biological Research 367:141-159 (1991) "Anti-lipopolysaccharide and anti-tumor necrosis . . . ".
Niven, et al., J. of Controlled Release 32:177-179 (1994) "Pulmonary absorption of polyethylene glycolated recombinant human . . . ".
Gorgen et al., J. Immunol. 149:418-924 (1992) "Granulocyte colony-stimulating factor treatment protects rodents against . . . ".
Lesslauer et al., Eur. J. Immunol. 21:2883-2886 (1991) "Recombinant soluble tumor necrosis factor proteins protect mice . . . ".
Zanetti et al., J. Immunol. 148:1890-1897 (1992) "Cytokine production after intravenous or peritoneal gram-negative . . . ".

Affiliated with

Also associated with

Rating

Compositions of G-CSF and TNF-BP for prophylaxis and treatment o does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions of G-CSF and TNF-BP for prophylaxis and treatment o, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions of G-CSF and TNF-BP for prophylaxis and treatment o will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-979102